Literature DB >> 9140333

Expenditures on services for persons with acquired immunodeficiency syndrome under a Medicaid home and community-based waiver program. Are selection effects important?

K H Anderson1, J M Mitchell.   

Abstract

OBJECTIVES: In 1990, the state of Florida implemented an acquired immunodeficiency syndrome (AIDS)-specific Medicaid waiver program to provide home and community-based services to AIDS patients as an alternative to institutional care. The program is available to Medicaid beneficiaries with AIDS who are at risk of institutionalization. This study examines whether the waiver option was effective in reducing Medicaid expenditures per beneficiary during its first 2 years of operation.
METHODS: The authors used Medicaid claims data and county information on the availability of health services to model the selection of the waiver option by AIDS patients and then to estimate the effect of the waiver on expenditures controlling for nonrandom program selection.
RESULTS: The results indicate that the selection model is highly significant, but that the influence of nonrandom selection on the estimation of the program effects is negligible. More importantly, the regression results indicate that persons with AIDS who use waiver services incur monthly Medicaid expenditures that are on average 22% to 27% lower than otherwise similar nonparticipants.
CONCLUSIONS: These results, based on the first 2 years that Project AIDS Care was operational, suggest that home and community-based care for AIDS patients results in lower expenditures per beneficiary.

Entities:  

Mesh:

Year:  1997        PMID: 9140333     DOI: 10.1097/00005650-199705000-00002

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  6 in total

1.  Home- and community-based waivers for children with autism: effects on service use and costs.

Authors:  Zuleyha Cidav; Steven C Marcus; David S Mandell
Journal:  Intellect Dev Disabil       Date:  2014-08

2.  Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial.

Authors:  S H Hamilton; D A Revicki; E T Edgell; L A Genduso; G Tollefson
Journal:  Pharmacoeconomics       Date:  1999-05       Impact factor: 4.981

3.  Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS.

Authors:  S Crystal; U Sambamoorthi; P J Moynihan; E McSpiritt
Journal:  J Gen Intern Med       Date:  2001-12       Impact factor: 5.128

4.  Florida's Medicaid AIDS waiver: an assessment of dimensions of quality.

Authors:  M E Cowart; J M Mitchell
Journal:  Health Care Financ Rev       Date:  1995

5.  Home-care use and expenditures among Medicaid beneficiaries with AIDS.

Authors:  U Sambamoorthi; S R Collins; S Crystal; J Walkup
Journal:  Health Care Financ Rev       Date:  1999

6.  Medicaid 1915(c) home and community-based services waivers across the states.

Authors:  A J LeBlanc; M C Tonner; C Harrington
Journal:  Health Care Financ Rev       Date:  2000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.